FDA, EMA Extend Joint Inspection Initiative to Generic Applications

Generic Line
A A
The FDA and EMA will expand their joint inspection activities to include facilities involved with bioequivalence studies for generic drug applications.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00